Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket



  • Connexa Sports Technologies Inc. CNXA shares rose 80.1% to $0.4161 in pre-market trading after declining around 7% on Thursday. CONNEXA, last month, announced a $5.0 million private placement.
  • Zovio Inc ZVO rose 16.8% to $0.1690 in pre-market trading.
  • Eargo, Inc. EAR rose 16.5% to $0.8269 in pre-market trading. Eargo announced that the record date for its proposed rights offering is October 24, 2022.
  • FedNat Holding Company FNHC rose 16.3% to $0.4089 in pre-market trading after jumping over 56% on Thursday.
  • IMARA Inc. IMRA rose 13.2% to $2.92 in pre-market trading. Enliven Therapeutics and Imara announced a merger agreement.
  • Avenue Therapeutics, Inc. ATXI shares rose 10.3% to $2.68 in pre-market trading after declining over 4% on Thursday.
  • WM Technology, Inc. MAPS shares rose 9.9% to $1.88 in pre-market trading.
  • Quanergy Systems, Inc. QNGY shares rose 9.3% to $2.00 in pre-market trading after dipping 16% on Thursday.
  • CarLotz, Inc. LOTZ rose 8% to $0.29 in pre-market trading.
  • Shuttle Pharmaceuticals Holdings, Inc. SHPH rose 7.7% to $3.47 in pre-market trading.
  • Digital Brands Group, Inc. DBGI shares rose 7.3% to $0.1180 in pre-market trading after the company finalizes new agreement for $20 million revenue Sunnyside, LLC acquisition, scheduled to close in November.
  • Black Diamond Therapeutics, Inc. BDTX rose 7.1% to $1.36 in pre-market trading after declining over 5% on Thursday.
  • Zai Lab Limited ZLAB rose 6% to $30.20 in pre-market trading. Seagen and Zai Lab recently announced an exclusive collaboration and license agreement for the development and commercialization of TIVDAK (tisotumab vedotin-tftv) in mainland China, Hong Kong, Macau, and Taiwan.

Don’t forget to check out our premarket coverage here .


  • Novo Integrated Sciences, Inc. NVOS fell 38.7% to $0.46 in pre-market trading after the company announced pricing of $2 million public offering of 4 million units at $0.50 per unit.
  • Nuwellis, Inc. NUWE fell 13.3% to $0.2880 in pre-market trading after dropping 10% on Thursday. Nuwellis recently announced results of the AVOID-HF clinical study analysis at the 2022 HFSA meeting, showing a "statistically superior clinical benefit of Aquadex therapy in reducing heart failure events and mortality."
  • Nutex Health Inc. NUTX fell 10.8% to $0.8512 in pre-market trading after jumping 72% on Thursday. Nutex recently provided a corporate update.
  • Gravitas Education Holdings, Inc. GEHI shares fell 9.2% to $13.62 in pre-market trading after surging around 14% on Thursday.
  • Romeo Power, Inc. RMO shares fell 8.7% to $0.33 in pre-market trading. Nikola completed exchange offer to acquire Romeo Power common stock.
  • Oblong, Inc. OBLG shares fell 7.7% to $0.2123 in pre-market trading after climbing over 26% on Thursday.
  • Qualigen Therapeutics, Inc QLGN fell 7.1% to $0.2510 in pre-market trading.
  • Plus Therapeutics, Inc. PSTV fell 6.7% to $0.4750 in pre-market trading. JonesTrading, last week, initiated coverage on the stock with a Buy rating and $5 price target.
  • China SXT Pharmaceuticals, Inc. SXTC shares fell 6.6% to $0.6180 in pre-market trading. On October 11, China SXT Pharmaceuticals received the funds from Mr. Xiao who previously agreed to purchase 1,625,798 shares of the company, par value $0.08/share at a per share purchase price of $1.35.
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!